Skip to main content
PMC home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1986 Oct;145(4):493–496.

Activated Charcoal—Past, Present and Future

Robert W Derlet 1,2, Timothy E Albertson 1,2
PMCID: PMC1306980  PMID: 3538661

Abstract

Poisoned patients were first treated with charcoal more than 150 years ago. Despite its almost universal acceptance today, activated charcoal's role has been overshadowed by the emphasis on treating poisoned patients first with gastric emptying. We review the current use of activated charcoal and recent studies that suggest that activated charcoal may be the single most effective treatment in many types of poisoning. New explanations for the mechanisms of action include “back diffusion” and disruption of enterohepatic loops. Clinical data endorse a new and aggressive role for activated charcoal in the management of poisoned and overdosed patients.

Full text

PDF
494

Images in this article

495Figure 1.
on p.495
495Figure 2.
on p.495
495Figure 3.
on p.495

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albertson T. E., Fisher C. J., Jr, Shragg T. A., Baselt R. C. A prolonged severe intoxication after ingestion of phenytoin and phenobarbital. West J Med. 1981 Nov;135(5):418–422. [PMC free article] [PubMed] [Google Scholar]
  2. Albertson T. E., Olson K. R., Fisher C. J. Emergency medicine: the use of activated charcoal in cases of poisoning and drug overdose. West J Med. 1985 Mar;142(3):385–386. [PMC free article] [PubMed] [Google Scholar]
  3. Berg M. J., Berlinger W. G., Goldberg M. J., Spector R., Johnson G. F. Acceleration of the body clearance of phenobarbital by oral activated charcoal. N Engl J Med. 1982 Sep 9;307(11):642–644. doi: 10.1056/NEJM198209093071102. [DOI] [PubMed] [Google Scholar]
  4. Berlinger W. G., Spector R., Goldberg M. J., Johnson G. F., Quee C. K., Berg M. J. Enhancement of theophylline clearance by oral activated charcoal. Clin Pharmacol Ther. 1983 Mar;33(3):351–354. doi: 10.1038/clpt.1983.44. [DOI] [PubMed] [Google Scholar]
  5. Burton B. T., Bayer M. J., Barron L., Aitchison J. P. Comparison of activated charcoal and gastric lavage in the prevention of aspirin absorption. J Emerg Med. 1984;1(5):411–416. doi: 10.1016/0736-4679(84)90203-8. [DOI] [PubMed] [Google Scholar]
  6. Cooney D. O. A "superactive" charcoal for antidotal use in poisonings. Clin Toxicol. 1977;11(4):387–390. doi: 10.3109/15563657708988201. [DOI] [PubMed] [Google Scholar]
  7. Corby D. G., Decker W. J., Moran M. J., Payne C. E. Clinical comparison of pharmacologic emetics in children. Pediatrics. 1968 Aug;42(2):361–364. [PubMed] [Google Scholar]
  8. Crome P., Dawling S., Braithwaite R. A., Masters J., Walkey R. Effect of activated charcoal on absorption of nortriptyline. Lancet. 1977 Dec 10;2(8050):1203–1205. doi: 10.1016/s0140-6736(77)90440-8. [DOI] [PubMed] [Google Scholar]
  9. Curtis R. A., Barone J., Giacona N. Efficacy of ipecac and activated charcoal/cathartic. Prevention of salicylate absorption in a simulated overdose. Arch Intern Med. 1984 Jan;144(1):48–52. [PubMed] [Google Scholar]
  10. Decker W. J., Combs H. F., Corby D. G. Adsorption of drugs and poisons by activated charcoal. Toxicol Appl Pharmacol. 1968 Nov;13(3):454–460. doi: 10.1016/0041-008x(68)90122-1. [DOI] [PubMed] [Google Scholar]
  11. Gal P., Miller A., McCue J. D. Oral activated charcoal to enhance theophylline elimination in an acute overdose. JAMA. 1984 Jun 15;251(23):3130–3131. [PubMed] [Google Scholar]
  12. Goldberg M. J., Berlinger W. G. Treatment of phenobarbital overdose with activated charcoal. JAMA. 1982 May 7;247(17):2400–2401. [PubMed] [Google Scholar]
  13. Greensher J., Mofenson H. C., Picchioni A. L., Fallon P. Activated charcoal updated. JACEP. 1979 Jul;8(7):261–263. doi: 10.1016/s0361-1124(79)80220-8. [DOI] [PubMed] [Google Scholar]
  14. HOLT L. E., Jr, HOLZ P. H. THE BLACK BOTTLE. A CONSIDERATION OF THE ROLE OF CHARCOAL IN THE TREATMENT OF POISONING IN CHILDREN. J Pediatr. 1963 Aug;63:306–314. doi: 10.1016/s0022-3476(63)80344-3. [DOI] [PubMed] [Google Scholar]
  15. Hayden J. W., Comstock E. G. Use of activated charcoal in acute poisoning. Clin Toxicol. 1975;8(5):515–533. doi: 10.3109/15563657508988096. [DOI] [PubMed] [Google Scholar]
  16. Kulig K., Bar-Or D., Cantrill S. V., Rosen P., Rumack B. H. Management of acutely poisoned patients without gastric emptying. Ann Emerg Med. 1985 Jun;14(6):562–567. doi: 10.1016/s0196-0644(85)80780-0. [DOI] [PubMed] [Google Scholar]
  17. Lalonde R. L., Deshpande R., Hamilton P. P., McLean W. M., Greenway D. C. Acceleration of digoxin clearance by activated charcoal. Clin Pharmacol Ther. 1985 Apr;37(4):367–371. doi: 10.1038/clpt.1985.55. [DOI] [PubMed] [Google Scholar]
  18. Levy G. Gastrointestinal clearance of drugs with activated charcoal. N Engl J Med. 1982 Sep 9;307(11):676–678. doi: 10.1056/NEJM198209093071109. [DOI] [PubMed] [Google Scholar]
  19. Levy G., Tsuchiya T. Effect of activated charcoal on aspirin absorption in man. Part I. Clin Pharmacol Ther. 1972 May-Jun;13(3):317–322. doi: 10.1002/cpt1972133317. [DOI] [PubMed] [Google Scholar]
  20. McDougal C. B., Maclean M. A. Modifications in the technique of gastric lavage. Ann Emerg Med. 1981 Oct;10(10):514–517. doi: 10.1016/s0196-0644(81)80005-4. [DOI] [PubMed] [Google Scholar]
  21. Neuvonen P. J. Clinical pharmacokinetics of oral activated charcoal in acute intoxications. Clin Pharmacokinet. 1982 Nov-Dec;7(6):465–489. doi: 10.2165/00003088-198207060-00001. [DOI] [PubMed] [Google Scholar]
  22. Neuvonen P. J., Elonen E. Effect of activated charcoal on absorption and elimination of phenobarbitone, carbamazepine and phenylbutazone in man. Eur J Clin Pharmacol. 1980 Jan;17(1):51–57. doi: 10.1007/BF00561677. [DOI] [PubMed] [Google Scholar]
  23. Neuvonen P. J., Vartiainen M., Tokola O. Comparison of activated charcoal and ipecac syrup in prevention of drug absorption. Eur J Clin Pharmacol. 1983;24(4):557–562. doi: 10.1007/BF00609903. [DOI] [PubMed] [Google Scholar]
  24. Picchioni A. L., Chin L., Laird H. E. Activated charcoal preparations--relative antidotal efficacy. Clin Toxicol. 1974;7(1):97–108. doi: 10.3109/15563657408987981. [DOI] [PubMed] [Google Scholar]
  25. Pond S. M., Olson K. R., Osterloh J. D., Tong T. G. Randomized study of the treatment of phenobarbital overdose with repeated doses of activated charcoal. JAMA. 1984 Jun 15;251(23):3104–3108. [PubMed] [Google Scholar]
  26. Pond S., Jacobs M., Marks J., Garner J., Goldschlager N., Hansen D. Treatment of digitoxin overdose with oral activated charcoal. Lancet. 1981 Nov 21;2(8256):1177–1178. doi: 10.1016/s0140-6736(81)90632-2. [DOI] [PubMed] [Google Scholar]
  27. Reigart J. R., Trammel H. L., Jr, Lindsey J. M. Repetitive doses of activated charcoal in Dapsone poisoning in a child. J Toxicol Clin Toxicol. 1982 Dec;19(10):1061–1066. doi: 10.3109/15563658208992541. [DOI] [PubMed] [Google Scholar]
  28. Riegel J. M., Becker C. E. Use of cathartics in toxic ingestions. Ann Emerg Med. 1981 May;10(5):254–258. doi: 10.1016/s0196-0644(81)80051-0. [DOI] [PubMed] [Google Scholar]
  29. True R. J., Berman J. M., Mahutte C. K. Treatment of theophylline toxicity with oral activated charcoal. Crit Care Med. 1984 Feb;12(2):113–114. doi: 10.1097/00003246-198402000-00006. [DOI] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES